A universal infant vaccination campaign in China has led the hepatitis B virus to more than double its rate of “breakout” mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.
A universal infant vaccination campaign in China has led the hepatitis B virus to more than double its rate of “breakout” mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.